2009. Bone marrow-derived mesenchymal stem cell therapy for neurodegenerative dis- eases. Expert Opin Biol Ther. 9:1487-1497.Sadan, O.; Melamed, E.; Offen, D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative dis- eases. Expert Opin. Biol. Ther. 9:1487-1497; 2009....
当当中国进口图书旗舰店在线销售正版《【预订】Bone marrow stem cell therapy for stroke 9789811097416》。最新《【预订】Bone marrow stem cell therapy for stroke 9789811097416》简介、书评、试读、价格、图片等相关信息,尽在DangDang.com,网购《【预订】Bone marro
ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2024 - ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2024
Among these, stem cell therapy has been shown to have promising prospects and draws increasing attention. From commonly investigated bone marrow-derived mesenchymal stem cells (bMSCs) to emerging ACL-derived CD34+ stem cells, multiple stem cell types have been proven to be effective in accelerating...
Bone marrow-derived mesenchymal stem cells (BMMSCs) are currently considered one of the cell types with great clinical potential for cell-based therapy. When transplanted systemically, mesenchymal stem cells (MSCs) are able to migrate to sites of injury and exert their therapeutic action via paracri...
The swine with its large heart/body weight and similarities to the human cardiovascular system is a valuable pre-clinical animal model for stem cell therapy25. Our previous research has confirmed that bone marrow-derived mononuclear cells’ coronary delivery may improve cardiac function and positive ...
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.
Savitz' other stem cell studies forstrokeare using a regenerative therapy developed by Aldagen that uses a patient's own bone marrowstem cellsinjected into the carotid artery; and an umbilical cord-derived cell therapy that can be used "off-the-shelf," which he hopes to bring to community h...
Bergh J High-dose therapy with autologous bone marrow stem cell support in primary and metastatic human breast cancer, Acta Oncol , 34 (1995) 669–674.Bergh J. High-dose therapy with autologous bone marrow stem cell support in primary and metastatic human breast cancer -- a review. Acta ...
Administering to patients stem cells derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health. The results of the trial, called ...